These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 29428228)

  • 1. Incidence and costs of herpes zoster and postherpetic neuralgia in German adults aged ≥50 years: A prospective study.
    Schmidt-Ott R; Schutter U; Simon J; Nautrup BP; von Krempelhuber A; Gopala K; Anastassopoulou A; Guignard A; Curran D; Matthews S; Espié E
    J Infect; 2018 May; 76(5):475-482. PubMed ID: 29428228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above.
    Curran D; Schmidt-Ott R; Schutter U; Simon J; Anastassopoulou A; Matthews S
    BMC Infect Dis; 2018 Oct; 18(1):496. PubMed ID: 30285731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
    Pellissier JM; Brisson M; Levin MJ
    Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic Burden of Herpes Zoster ("culebrilla") in Latin America.
    Rampakakis E; Pollock C; Vujacich C; Toniolo Neto J; Ortiz Covarrubias A; Monsanto H; Johnson KD
    Int J Infect Dis; 2017 May; 58():22-26. PubMed ID: 28267595
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health economic evaluation of vaccination strategies for the prevention of herpes zoster and postherpetic neuralgia in Germany.
    Ultsch B; Weidemann F; Reinhold T; Siedler A; Krause G; Wichmann O
    BMC Health Serv Res; 2013 Sep; 13():359. PubMed ID: 24070414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Burden of herpes zoster and postherpetic neuralgia in Japanese adults 60 years of age or older: Results from an observational, prospective, physician practice-based cohort study.
    Sato K; Adachi K; Nakamura H; Asano K; Watanabe A; Adachi R; Kiuchi M; Kobayashi K; Matsuki T; Kaise T; Gopala K; Holl K
    J Dermatol; 2017 Apr; 44(4):414-422. PubMed ID: 27917531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes zoster and postherpetic neuralgia in Catalonia (Spain).
    Salleras L; Salleras M; Salvador P; Soldevila N; Prat A; Garrido P; Domínguez A
    Hum Vaccin Immunother; 2015; 11(1):178-84. PubMed ID: 25483532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology and cost of herpes zoster and postherpetic neuralgia in Germany.
    Ultsch B; Köster I; Reinhold T; Siedler A; Krause G; Icks A; Schubert I; Wichmann O
    Eur J Health Econ; 2013 Dec; 14(6):1015-26. PubMed ID: 23271349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Burden of disease from shingles and post-herpetic neuralgia in the over 80 year olds in the UK.
    Matthews I; Duong M; Parsons VL; Nozad B; Qizilbash N; Patel Y; Guimicheva B
    PLoS One; 2020; 15(2):e0229224. PubMed ID: 32097441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of herpes zoster and postherpetic neuralgia in Italian adults aged ≥50 years: A prospective study.
    Salvetti A; Ferrari V; Garofalo R; Gazzaniga P; Guerroni A; Metrucci A; Sessa A; Severi ML; Nati G; Ruggeri M; Rossi A; Cappellari L; Gopala K; Tosatto R; Simone B
    Prev Med Rep; 2019 Jun; 14():100882. PubMed ID: 31193254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom.
    Gauthier A; Breuer J; Carrington D; Martin M; Rémy V
    Epidemiol Infect; 2009 Jan; 137(1):38-47. PubMed ID: 18466661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study.
    Gialloreti LE; Merito M; Pezzotti P; Naldi L; Gatti A; Beillat M; Serradell L; di Marzo R; Volpi A
    BMC Infect Dis; 2010 Aug; 10():230. PubMed ID: 20682044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia.
    Friesen KJ; Chateau D; Falk J; Alessi-Severini S; Bugden S
    BMC Infect Dis; 2017 Jan; 17(1):69. PubMed ID: 28086817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of postherpetic neuralgia in patients with herpes zoster: a pooled analysis of prospective cohort studies from North and Latin America and Asia.
    Kawai K; Rampakakis E; Tsai TF; Cheong HJ; Dhitavat J; Covarrubias AO; Yang L; Cashat-Cruz M; Monsanto H; Johnson K; Sampalis JS; Acosta CJ
    Int J Infect Dis; 2015 May; 34():126-31. PubMed ID: 25841633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of postherpetic neuralgia among patients with herpes zoster: a prospective study.
    Drolet M; Brisson M; Schmader K; Levin M; Johnson R; Oxman M; Patrick D; Camden S; Mansi JA
    J Pain; 2010 Nov; 11(11):1211-21. PubMed ID: 20434957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of a vaccination program for the prevention of herpes zoster and post-herpetic neuralgia in adults aged 50 and over in Germany.
    Préaud E; Uhart M; Böhm K; Aidelsburger P; Anger D; Bianic F; Largeron N
    Hum Vaccin Immunother; 2015; 11(4):884-96. PubMed ID: 25933182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and cost of herpes zoster and postherpetic neuralgia among patients treated in primary care centres in the Valencian community of Spain.
    Cebrián-Cuenca AM; Díez-Domingo J; San-Martín-Rodríguez M; Puig-Barberá J; Navarro-Pérez J;
    BMC Infect Dis; 2011 Nov; 11():302. PubMed ID: 22044665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herpes zoster and postherpetic neuralgia: optimizing management in the elderly patient.
    Johnson RW; Wasner G; Saddier P; Baron R
    Drugs Aging; 2008; 25(12):991-1006. PubMed ID: 19021299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidences of Herpes Zoster and Postherpetic Neuralgia in Japanese Adults Aged 50 Years and Older From a Community-based Prospective Cohort Study: The SHEZ Study.
    Takao Y; Miyazaki Y; Okeda M; Onishi F; Yano S; Gomi Y; Ishikawa T; Okuno Y; Mori Y; Asada H; Yamanishi K; Iso H
    J Epidemiol; 2015; 25(10):617-25. PubMed ID: 26399445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential cost-effectiveness of vaccination against herpes zoster and post-herpetic neuralgia.
    Brisson M; Pellissier JM; Camden S; Quach C; De Wals P
    Hum Vaccin; 2008; 4(3):238-45. PubMed ID: 18382137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.